Kenneth V. Honn / Bonnie F. Sloane (eds.)
Hemostatic Mechanisms and Metastasis
Herausgegeben:Honn, Kenneth V.; Sloane, Bonnie F.
Kenneth V. Honn / Bonnie F. Sloane (eds.)
Hemostatic Mechanisms and Metastasis
Herausgegeben:Honn, Kenneth V.; Sloane, Bonnie F.
- Gebundenes Buch
Andere Kunden interessierten sich auch für
- Hemostatic Mechanisms and Metastasis166,99 €
- Kenneth V. Honn / William E. Powers / Bonnie F. Sloane (eds.)Mechanisms of Cancer Metastasis246,99 €
- Franco M. Muggia (ed.)Concepts, Clinical Developments, and Therapeutic Advances in Cancer Chemotherapy192,99 €
- Gregory T. Wolf (ed.)Head and Neck Oncology248,99 €
- MeyskensVitamins and Cancer123,99 €
- Daniel M. GreenDiagnosis and Management of Malignant Solid Tumors in Infants and Children313,99 €
- Frederick A. Valeriote / L.O. Baker (eds.)Biochemical Modulation of Anticancer Agents: Experimental and Clinical Approaches190,99 €
-
-
-
Produktdetails
- Developments in Oncology 22
- Verlag: Springer / Springer US / Springer, Berlin
- Artikelnr. des Verlages: 978-0-89838-667-7
- 1984.
- Seitenzahl: 432
- Erscheinungstermin: 31. Juli 1984
- Englisch
- Abmessung: 234mm x 156mm x 25mm
- Gewicht: 1810g
- ISBN-13: 9780898386677
- ISBN-10: 0898386675
- Artikelnr.: 24480897
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
1. Is there Clinical Relevance for Therapies which Disrupt the Metastatic Cascade?.- 2. Overview of the Metastatic Cascade.- 3. Overview on Blood Coagulation Proteins.- 4. The Microinjury Hypothesis and Metastasis.- 5. Hemostatic Abnormalities in Tumor-Bearing Animals.- 6. Evidence for a Tumor Proteinase in Blood Coagulation.- 7. Relationship between Procoagulant Activity and Metastatic Capacity of Tumor Cells.- 8. Fibrin Formation: Implications for Tumor Growth and Metastasis.- 9. Perspectives on the Role of Platelets in Hemostasis and Thrombosis.- 10. Mechanisms of Platelet Aggregation by Murine Tumor Cell Spheroids.- 11. Heterogenous Mechanisms of Tumor Cell-Induced Platelet Aggregation with Possible Pharmacological Strategy Toward Prevention of Metastases.- 12. Tumor Cysteine Proteinases, Platelet Aggregation and Metastasis.- 13. Arachidonate Metabolism in Platelets and Blood Vessels.- 14. Prostacyclin/Thromboxanes and Tumor Cell Metastasis.- 15. Evidence for Altered Arachidonic Acid Metabolism in Tumor Metastasis.- 16. Calcium Channel Blockers: Inhibitors of Tumor Cell-Platelet-Endothelial Cell Interactions.- 17. Evidence for the Antimetastatic Effects of Coumarin Derivatives.- 18. Mitogenic Stimulation of Tumor Cells by Platelet Derived Growth Factors.- 19. Role of the Vascular Endothelium in Hemostasis.- 20. The Cellular Interactions of Metastatic Tumor Cells with Special Reference to Endothelial Cells and their Basal Lamina-Like Matrix.- 21. Interaction of Tumor Cells with the Basement Membrane of Endothelium.- 22. Hemostatic Alterations in Cancer Patients.- 23. Historical Overview of Clinical Experience with Anticoagulant Therapy.- 24. Rationale for Anticoagulant Treatment of Cancer.- 25. The Design and Execution of Anticoagulant Therapy Trials in Cancer.- 26.Experimental and Clinical Experience with Pyrimido - Pyrimidine Derivatives in the Inhibition of Malignant Metastasis Formation.- 27. Current Clinical Trials with Anticoagulant Therapy in the Management of Cancer Patients.
1. Is there Clinical Relevance for Therapies which Disrupt the Metastatic Cascade?.- 2. Overview of the Metastatic Cascade.- 3. Overview on Blood Coagulation Proteins.- 4. The Microinjury Hypothesis and Metastasis.- 5. Hemostatic Abnormalities in Tumor-Bearing Animals.- 6. Evidence for a Tumor Proteinase in Blood Coagulation.- 7. Relationship between Procoagulant Activity and Metastatic Capacity of Tumor Cells.- 8. Fibrin Formation: Implications for Tumor Growth and Metastasis.- 9. Perspectives on the Role of Platelets in Hemostasis and Thrombosis.- 10. Mechanisms of Platelet Aggregation by Murine Tumor Cell Spheroids.- 11. Heterogenous Mechanisms of Tumor Cell-Induced Platelet Aggregation with Possible Pharmacological Strategy Toward Prevention of Metastases.- 12. Tumor Cysteine Proteinases, Platelet Aggregation and Metastasis.- 13. Arachidonate Metabolism in Platelets and Blood Vessels.- 14. Prostacyclin/Thromboxanes and Tumor Cell Metastasis.- 15. Evidence for Altered Arachidonic Acid Metabolism in Tumor Metastasis.- 16. Calcium Channel Blockers: Inhibitors of Tumor Cell-Platelet-Endothelial Cell Interactions.- 17. Evidence for the Antimetastatic Effects of Coumarin Derivatives.- 18. Mitogenic Stimulation of Tumor Cells by Platelet Derived Growth Factors.- 19. Role of the Vascular Endothelium in Hemostasis.- 20. The Cellular Interactions of Metastatic Tumor Cells with Special Reference to Endothelial Cells and their Basal Lamina-Like Matrix.- 21. Interaction of Tumor Cells with the Basement Membrane of Endothelium.- 22. Hemostatic Alterations in Cancer Patients.- 23. Historical Overview of Clinical Experience with Anticoagulant Therapy.- 24. Rationale for Anticoagulant Treatment of Cancer.- 25. The Design and Execution of Anticoagulant Therapy Trials in Cancer.- 26.Experimental and Clinical Experience with Pyrimido - Pyrimidine Derivatives in the Inhibition of Malignant Metastasis Formation.- 27. Current Clinical Trials with Anticoagulant Therapy in the Management of Cancer Patients.